Mangiferin and an anti-cancer treatment decreased cell viability, which was attributed to increased Noxa and p53 expression and decreased XIAP, Bcl-xL, and survival protein expression via inhibiting the NF-kB pathway [98] (Table 2). The gene discussed is NFKB1; the disease is cancer.